BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 27730394)

  • 1. Bif-1 promotes tumor cell migration and metastasis via Cdc42 expression and activity.
    Zhang C; Liu F; Chen H; Li N; Luo Z; Guo W; Huang D; Tang S; Wang H; Cheng S; Li Z; Wang H
    Clin Exp Metastasis; 2017 Jan; 34(1):11-23. PubMed ID: 27730394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Robo1 promotes angiogenesis in hepatocellular carcinoma through the Rho family of guanosine triphosphatases' signaling pathway.
    Ao JY; Chai ZT; Zhang YY; Zhu XD; Kong LQ; Zhang N; Ye BG; Cai H; Gao DM; Sun HC
    Tumour Biol; 2015 Nov; 36(11):8413-24. PubMed ID: 26022159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma.
    Xia L; Huang W; Tian D; Zhu H; Qi X; Chen Z; Zhang Y; Hu H; Fan D; Nie Y; Wu K
    Hepatology; 2013 Feb; 57(2):610-24. PubMed ID: 22911555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldolase B inhibits metastasis through Ten-Eleven Translocation 1 and serves as a prognostic biomarker in hepatocellular carcinoma.
    Tao QF; Yuan SX; Yang F; Yang S; Yang Y; Yuan JH; Wang ZG; Xu QG; Lin KY; Cai J; Yu J; Huang WL; Teng XL; Zhou CC; Wang F; Sun SH; Zhou WP
    Mol Cancer; 2015 Sep; 14():170. PubMed ID: 26376879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autophagy inhibition suppresses pulmonary metastasis of HCC in mice via impairing anoikis resistance and colonization of HCC cells.
    Peng YF; Shi YH; Ding ZB; Ke AW; Gu CY; Hui B; Zhou J; Qiu SJ; Dai Z; Fan J
    Autophagy; 2013 Dec; 9(12):2056-68. PubMed ID: 24157892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-34c-3p promotes cell proliferation and invasion in hepatocellular carcinoma by regulation of NCKAP1 expression.
    Xiao CZ; Wei W; Guo ZX; Zhang MY; Zhang YF; Wang JH; Shi M; Wang HY; Guo RP
    J Cancer Res Clin Oncol; 2017 Feb; 143(2):263-273. PubMed ID: 27704267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MTBP inhibits migration and metastasis of hepatocellular carcinoma.
    Bi Q; Ranjan A; Fan R; Agarwal N; Welch DR; Weinman SA; Ding J; Iwakuma T
    Clin Exp Metastasis; 2015 Apr; 32(4):301-11. PubMed ID: 25759210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A20 suppresses hepatocellular carcinoma proliferation and metastasis through inhibition of Twist1 expression.
    Chen H; Hu L; Luo Z; Zhang J; Zhang C; Qiu B; Dong L; Tan Y; Ding J; Tang S; Shen F; Li Z; Wang H
    Mol Cancer; 2015 Nov; 14():186. PubMed ID: 26538215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hornerin promotes tumor progression and is associated with poor prognosis in hepatocellular carcinoma.
    Fu SJ; Shen SL; Li SQ; Hua YP; Hu WJ; Guo B; Peng BG
    BMC Cancer; 2018 Aug; 18(1):815. PubMed ID: 30103712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression analysis of Cdc42 in lung cancer and modulation of its expression by curcumin in lung cancer cell lines.
    Chen QY; Jiao DM; Yao QH; Yan J; Song J; Chen FY; Lu GH; Zhou JY
    Int J Oncol; 2012 May; 40(5):1561-8. PubMed ID: 22266952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.
    Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K
    J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition.
    Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z
    Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenic function and prognostic significance of Abelson interactor 1 in hepatocellular carcinoma.
    Wang JL; Yan TT; Long C; Cai WW
    Int J Oncol; 2017 May; 50(5):1889-1898. PubMed ID: 28339046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ANGPTL2 promotes tumor metastasis in hepatocellular carcinoma.
    Gao L; Ge C; Fang T; Zhao F; Chen T; Yao M; Li J; Li H
    J Gastroenterol Hepatol; 2015 Feb; 30(2):396-404. PubMed ID: 25090954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased expression of ARID1A associates with poor prognosis and promotes metastases of hepatocellular carcinoma.
    He F; Li J; Xu J; Zhang S; Xu Y; Zhao W; Yin Z; Wang X
    J Exp Clin Cancer Res; 2015 May; 34(1):47. PubMed ID: 25975202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-195 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting the expression of VEGF, VAV2, and CDC42.
    Wang R; Zhao N; Li S; Fang JH; Chen MX; Yang J; Jia WH; Yuan Y; Zhuang SM
    Hepatology; 2013 Aug; 58(2):642-53. PubMed ID: 23468064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA UC001kfo promotes hepatocellular carcinoma proliferation and metastasis by targeting α-SMA.
    Pan Y; Qin T; Yin S; Zhang X; Gao X; Mu L
    Biomed Pharmacother; 2017 Mar; 87():669-677. PubMed ID: 28088733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of cell proliferation and metastasis of human hepatocellular carcinoma by miR-137 is regulated by CDC42.
    Gao M; Liu L; Li S; Zhang X; Chang Z; Zhang M
    Oncol Rep; 2015 Nov; 34(5):2523-32. PubMed ID: 26352279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GIT1 promotes lung cancer cell metastasis through modulating Rac1/Cdc42 activity and is associated with poor prognosis.
    Chang JS; Su CY; Yu WH; Lee WJ; Liu YP; Lai TC; Jan YH; Yang YF; Shen CN; Shew JY; Lu J; Yang CJ; Huang MS; Lu PJ; Lin YF; Kuo ML; Hua KT; Hsiao M
    Oncotarget; 2015 Nov; 6(34):36278-91. PubMed ID: 26462147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous cell injury promotes hepatic tumorigenesis in cdc42-deficient mouse liver.
    van Hengel J; D'Hooge P; Hooghe B; Wu X; Libbrecht L; De Vos R; Quondamatteo F; Klempt M; Brakebusch C; van Roy F
    Gastroenterology; 2008 Mar; 134(3):781-92. PubMed ID: 18325391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.